Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Iaffaldano

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 3, 2009
Safety profile of Tysabri: international risk management planP Iaffaldano, M D'Onghia, Maria Trojano
Journal of the Neurological Sciences|May 1, 2013
Verbal fluency deficits in clinically isolated syndrome suggestive of multiple sclerosisR G Viterbo, P Iaffaldano, M Trojano
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 13, 2026
Safety issues during treatment sequencing in multiple sclerosis: first case of mycosis fungoides during anti CD 20 therapyA Teofilo, F Caputo, V Mangialardi, et al.
European Journal of Neurology|October 15, 2020
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis RegisterV Lepore, C Bosetti, C Santucci, et al.
Journal of Neurology|February 19, 2013
The impact of neutralizing antibodies on the risk of disease worsening in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing studyD Paolicelli, M D'Onghia, F Pellegrini, et al.
European Journal of Clinical Pharmacology|June 3, 2016
The role of neutralizing antibodies to interferon-β as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational studyDamiano Paolicelli, A Manni, A Iaffaldano, et al.
Clinical Nephrology|December 31, 2009
Emotional symptoms, quality of life and cytokine profile in hemodialysis patientsV Montinaro, G P Iaffaldano, S Granata, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2013
Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trialM P Amato, B Goretti, R G Viterbo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 28, 2013
Anxiety state affects information processing speed in patients with multiple sclerosisBenedetta Goretti, R G Viterbo, E Portaccio, et al.
Journal of Neuroimmunology|January 4, 2017
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patientsD Paolicelli, A Manni, M D'Onghia, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 3, 2009
Safety profile of Tysabri: international risk management planP Iaffaldano, M D'Onghia, Maria Trojano
Journal of the Neurological Sciences|May 1, 2013
Verbal fluency deficits in clinically isolated syndrome suggestive of multiple sclerosisR G Viterbo, P Iaffaldano, M Trojano
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 13, 2026
Safety issues during treatment sequencing in multiple sclerosis: first case of mycosis fungoides during anti CD 20 therapyA Teofilo, F Caputo, V Mangialardi, et al.
European Journal of Neurology|October 15, 2020
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis RegisterV Lepore, C Bosetti, C Santucci, et al.
Journal of Neurology|February 19, 2013
The impact of neutralizing antibodies on the risk of disease worsening in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing studyD Paolicelli, M D'Onghia, F Pellegrini, et al.
European Journal of Clinical Pharmacology|June 3, 2016
The role of neutralizing antibodies to interferon-β as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational studyDamiano Paolicelli, A Manni, A Iaffaldano, et al.
Clinical Nephrology|December 31, 2009
Emotional symptoms, quality of life and cytokine profile in hemodialysis patientsV Montinaro, G P Iaffaldano, S Granata, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2013
Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trialM P Amato, B Goretti, R G Viterbo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 28, 2013
Anxiety state affects information processing speed in patients with multiple sclerosisBenedetta Goretti, R G Viterbo, E Portaccio, et al.
Journal of Neuroimmunology|January 4, 2017
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patientsD Paolicelli, A Manni, M D'Onghia, et al.
Pageof 2